Chargement en cours...
Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the mechanism of its onset. The present study assessed t...
Enregistré dans:
| Publié dans: | Exp Ther Med |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840744/ https://ncbi.nlm.nih.gov/pubmed/27168803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3133 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|